| __timestamp | MorphoSys AG | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55962693 | 5280000 |
| Thursday, January 1, 2015 | 78655788 | 7148000 |
| Friday, January 1, 2016 | 95723069 | 19594000 |
| Sunday, January 1, 2017 | 116808575 | 22894000 |
| Monday, January 1, 2018 | 106397017 | 50337000 |
| Tuesday, January 1, 2019 | 108431600 | 109450000 |
| Wednesday, January 1, 2020 | 141426832 | 90450000 |
| Friday, January 1, 2021 | 225200000 | 104128000 |
| Saturday, January 1, 2022 | 297812160 | 108630000 |
| Sunday, January 1, 2023 | 283614139 | 134951000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, MorphoSys AG and Rhythm Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, MorphoSys AG consistently outpaced Rhythm Pharmaceuticals in R&D spending, with a peak in 2022 where their investment was nearly 2.8 times higher than Rhythm's. Notably, MorphoSys's R&D expenses surged by approximately 400% from 2014 to 2023, reflecting their aggressive pursuit of new therapies. In contrast, Rhythm Pharmaceuticals showed a more gradual increase, with a notable spike in 2023, reaching 1.35 times their 2019 spending.
These trends highlight the differing approaches to innovation, with MorphoSys focusing on sustained high investment, while Rhythm Pharmaceuticals adopts a more measured, yet increasingly ambitious, strategy.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Research and Development: Comparing Key Metrics for GSK plc and Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Genmab A/S vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and MorphoSys AG
R&D Spending Showdown: CRISPR Therapeutics AG vs MorphoSys AG
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
Research and Development Expenses Breakdown: Perrigo Company plc vs MorphoSys AG